| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1415 | Cid-44330438 | Novel Inhibitor of the Major Facilitator Superfamily (MFS) of Efflux Pump Transporters. |
|
| DCC1416 | Cid-4970947 | Potent inhibitor of cancer cell growth with microtubule-binding activity |
|
| DCC1417 | Cid-5056270 | Potent inhibitor of ROCK2 enzymatic activity |
|
| DCC1418 | cid-50930756 | Novel Stimulator of Hepatitis C Virus NS3 Helicase-Catalyzed ATP Hydrolysis |
|
| DCC1419 | cid-5712383 | Potent inhibitor of HIV-1 nucleocapsid (NC)-DNA interaction; specifically bound NC with nanomolar affinity, and showed modest anti-HIV-1 activity in ex vivo cell assays |
|
| DCC1420 | Cid-663143 | Potent inhibitor of cancer cell growth with microtubule-binding activity |
|
| DCC1421 | cid-697851 | Novel specific inhibitor of bacterial AddAB helicase-nuclease DNA repair enzyme |
|
| DCC1422 | Cid-715454 | Inhibitor of PLAP and TNAP |
|
| DCC1423 | Cid-7309015 | Inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1); Delayed death inhibitor of the malarial parasite plastid; Inhibitor of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1); Inhibit |
|
| DCC1424 | Cid-877874 | Platelet activation inhibitor |
|
| DCC1425 | Cid-948801 | Novel 3C-like protease inhibitor of SARS-CoV-2 |
|
| DCC1426 | Cigb-814 | Altered peptide ligand containing a novel CD4 T-cell epitope of human heat shock protein 60 (83-109) |
|
| DCC1427 | Ci-ip3/pm | Cell permeable caged inositol triphosphate, promoting Ca2+-release from internal stores under UV photolysis |
|
| DCC1428 | Cilofungin | Noncompetitive inhibitor of Candida albicans growth and activity of (1-3)-beta-glucan synthase |
|
| DCC1429 | Cimaterol | ß-Adrenergic agonist |
|
| DCC1430 | cinanserin | 5-HT2 antagonist |
|
| DCC1431 | Cinitapride Tartrate | Agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors |
|
| DCC1432 | Cinromide | Novel modulator of SLC6A19, robustly, selectively, and reproducibly inhibiting SLC6A19 |
|
| DCC1433 | Ciprofloxacin Hydrochloride Hydrate | Broad-spectrum antimicrobial carboxyfluoroquinoline, interfering with the bacterial DNA gyrase, inhibiting the DNA synthesis, and preventing bacterial cell growth |
|
| DCC1434 | Ciraparantag Acetate | Non-Specific Anticoagulant Reversal Agent |
|
| DCC1435 | Cis,cis-2,6-dimethylcyclohexanol | Positive modulator of GABA A receptors |
|
| DCC1436 | Cis-3-4-dihydrohamacanthin B | Potent inhibitor of MRSA PK |
|
| DCC1437 | Cis-4-d-hyp-d-ser Hydrochloride | JBP923 analog, exerting potent therapeutic effect on inflammatory bowel disease (IBD) |
|
| DCC1438 | Cis-cinnamic Acid | Novel, natural auxin efflux inhibitor, promoting lateral root formation |
|
| DCC1439 | Cis-vz185 | Negative control for VZ185 |
|
| DCC1440 | Cj-054 | Polo-like kinase 1 (Plk1) inhibitor |
|
| DCC1441 | Cj-1383 | Novel Cell-Permeable STAT3 Inhibitor, targeting the SH2 domain |
|
| DCC1442 | Cj-15208 | Biological Active Reagents |
|
| DCC1443 | Cj-1882 | Potent and competitive antagonist at the human D3 receptor |
|
| DCC1444 | Cj2100 | Novel potent muscarinic antagonist wirh antimuscarinic antidepressant-like activities, showing modest affinity across the mAChRs when compared to L-687306 and scopolamine |
|
